2025-520642-29-00Not yet recruitingPhase 2
Evaluation of the regenerative efficacy of Endoret® (PRGF-Plasm Rich in Growth Factors) on the ocular surface of glaucoma patients treated chronically with ocular hypotensive drugs, Evaluación de la eficacia regenerativa de Endoret® (PRGF-Plasma Rico en Factores de Crecimiento) en la superficie ocular de pacientes glaucomatosos tratados de forma crónica con fármacos hipotensores oculares
Source: EU CTIS (euclinicaltrials.eu) · Last updated 29 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To assess the changes in tear osmolarity after topical treatment with PRGF.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 27 Jan 2025
- Start date
- 22 Jan 2025
- Lead sponsor
- Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
- Diseases
- Glaucoma
- EU CT number
- 2025-520642-29-00
- EudraCT number
- 2019-001647-46
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 30
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Ocular surface pathology other than toxicity due to ocular hypotensive drugs.
- Previous ocular surface surgeries.
- Treatment with topical blood derivatives in the last 6 months.
Other illness
- Allergy to local anesthetics.
Age
- Women of childbearing age with pregnancy intention, pregnant women, and breastfeeding women.
Who the study is looking for
- Adult patients diagnosed with glaucoma who are undergoing treatment with at least two ocular hypotensive drugs (3 drops/day) without preservatives for a minimum of the last two years and who consent to participate in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital de la Santa Creu i Sant Pau | Barcelona | Spain | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.